Big pharmacy with spikes in my eyes
Release time:
2021-03-22
This year is the 2nd anniversary of the establishment of the Peak Pharmacy 20#. I have been in the Peak Pharmacy since 2020 3# June, and it is almost a year before I know it. 2020
is destined to be an extraordinary year, when I entered the big pharmacy, or during the new crown epidemic, everyone in the pharmacy strictly in accordance with the requirements to do a good job of epidemic prevention, to ensure the supply of epidemic prevention materials, do a good job of registration and guard the first line of epidemic prevention and control work"small door " . The big pharmacy is very caring for our employees and regularly distributes epidemic prevention supplies to protect ourselves. The big pharmacy also carried out public welfare activities for medical staff in Hubei, reflecting the social responsibility of the big pharmacy.
In addition, Jianfeng Pharmacy has set up an automatic drug selling service point in Jinhua Shuanglong Scenic Area, equipped with more than40 kinds of drugs such as heatstroke prevention and cooling drugs, motion sickness drugs, mosquito bites and traumatic injuries, which have solved the urgent needs of tourists visiting the mountain and won favorable comments from the majority of tourists. The number of designated retail pharmacies for chronic diseases in large pharmacies has also increased from one to three, especially the increase in Jindong District. It has brought great convenience to patients with chronic diseases outside the urban area and can buy all kinds of drugs they need nearby. The big pharmacy will also integrate into the community at ordinary times, providing convenient services such as health lectures and free consultation to the citizens ...
As a new employee, I can't do many operations at the beginning, and the seniors in the store will patiently guide and help me. They are very careful in their work, treat customers sincerely and enthusiastically, answer customers' doubts, ask for diseases and sell medicines, and provide customers with the best service. I learned from them how to communicate with customers. When I encounter problems at work, they will teach me how to solve them. This makes me feel the love and warmth of the big family as a new employee. The pharmacy is also very concerned about the growth of employees. It will organize group building activities to enrich employees' amateur cultural life, bring spiritual wealth to employees, provide a stage for employees to display their talents, and let employees maintain their passion and realize their own value.During the 20 years of ups and downs, Jianfeng Pharmacy has always insisted on providing high-quality and professional services to the public, grateful customers and caring for employees, creating more value for the society and providing more platforms for employees to realize their own value. In the past 20 years, we have carried forward the past and forged ahead.
2021 is a new starting point. (Tianfutang Feng Danqing)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31